Trial record 23 of 65 for:    dry mouth | NIH

Vismodegib in Treating Patients With Steroid-Refractory Chronic Graft-Versus-Host Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02337517
Recruitment Status : Recruiting
First Posted : January 13, 2015
Last Update Posted : November 21, 2018
Genentech, Inc.
Information provided by (Responsible Party):
National Cancer Institute (NCI)

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : August 1, 2020
  Study Completion Date : No date given